Carregant...

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

Cancer immunotherapy using the adoptive transfer of autologous tumor-infiltrating lymphocytes results in objective cancer regression in 49–72% of patients with metastatic melanoma. In a pilot trial combining cell transfer with a maximum lymphodepleting regimen, complete durable responses were seen i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Rev Clin Oncol
Autor principal: Rosenberg, Steven A.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292196/
https://ncbi.nlm.nih.gov/pubmed/21808266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2011.116
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!